Ligand Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ligand Pharmaceuticals's estimated annual revenue is currently $21.2M per year.
- Ligand Pharmaceuticals's estimated revenue per employee is $155,000
- Ligand Pharmaceuticals's total funding is $875M.
Employee Data
- Ligand Pharmaceuticals has 137 Employees.
- Ligand Pharmaceuticals grew their employee count by -14% last year.
Ligand Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Assistant General Counsel & Chief Patent Counsel | Reveal Email/Phone |
2 | VP, Chemistry & Pharmaceutical Sciences | Reveal Email/Phone |
3 | SVP, Biology & Scientific Affairs | Reveal Email/Phone |
4 | SVP, Investments and Business Development | Reveal Email/Phone |
5 | VP, Protein Sciences | Reveal Email/Phone |
6 | VP, Corporate Controller | Reveal Email/Phone |
7 | VP, New Product Development | Reveal Email/Phone |
8 | VP, Protein Sciences | Reveal Email/Phone |
9 | SVP, Technical Operations and QA | Reveal Email/Phone |
10 | SVP Clinical Strategy and Investments | Reveal Email/Phone |
Ligand Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ligand Pharmaceuticals?
Ligand Pharmaceuticals is a royalty-driven biotechnology company with strong research and drug discovery capabilities. We have numerous valuable corporate partnerships, a broad product pipeline targeting large markets, proven scientific credentials in combination with partners and a strong balance sheet.
keywords:N/A$875M
Total Funding
137
Number of Employees
$21.2M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ligand Pharmaceuticals News
Ligand Pharmaceuticals, Addrenex Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Arena Pharmaceuticals,...
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical...
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) acquired Ab Initio Biotherapeutics, an antigen-discovery company based in South San Francisco, California, for $12m. Ab Initio brings to Ligand patented antigen technology that is synergistic with its OmniAb® therapeutic antibody discovery plat ...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a San Diego, CA-based biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines, is to acquire Vernalis plc (LSE: VER), a structure-based drug discovery biotechno ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.4M | 137 | -4% | N/A |
#2 | $28.8M | 137 | 14% | N/A |
#3 | $19.9M | 137 | 10% | N/A |
#4 | $19.9M | 137 | 10% | N/A |
#5 | $27.5M | 137 | -4% | N/A |